These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36782401)

  • 41. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature.
    Anees Ur Rehman ; Ahmad Hassali MA; Muhammad SA; Shah S; Abbas S; Hyder Ali IAB; Salman A
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):661-672. PubMed ID: 31596632
    [No Abstract]   [Full Text] [Related]  

  • 42. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunisation of healthcare workers in the Nordic countries: Variation in recommendations and practices and a lack of assessment.
    Dub T; Søborg B; Andersen PH; Gudnason T; Nøkleby H; Lindstrand A; Carlsson RM; Nohynek H
    Euro Surveill; 2021 Jan; 26(4):. PubMed ID: 33509337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suicide mortality trends in the Nordic countries 1980-2009.
    Titelman D; Oskarsson H; Wahlbeck K; Nordentoft M; Mehlum L; Jiang GX; Erlangsen A; Nrugham L; Wasserman D
    Nord J Psychiatry; 2013 Dec; 67(6):414-23. PubMed ID: 23293897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Burden of disease due to transportation noise in the Nordic countries.
    Aasvang GM; Stockfelt L; Sørensen M; Turunen AW; Roswall N; Yli-Tuomi T; Ögren M; Lanki T; Selander J; Vincens N; Pyko A; Pershagen G; Sulo G; Bølling AK
    Environ Res; 2023 Aug; 231(Pt 1):116077. PubMed ID: 37156356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Societal Cost of Schizophrenia: A Systematic Review.
    Jin H; Mosweu I
    Pharmacoeconomics; 2017 Jan; 35(1):25-42. PubMed ID: 27557994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fatal poisoning in drug addicts in the Nordic countries in 2017.
    Simonsen KW; Kriikku P; Thelander G; Edvardsen HME; Thordardottir S; Andersen CU; Jönsson AK; Frost J; Christoffersen DJ; Delaveris GJM; Ojanperä I
    Forensic Sci Int; 2020 Aug; 313():110343. PubMed ID: 32563797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The economic cost of preventable disease in Australia: a systematic review of estimates and methods.
    Crosland P; Ananthapavan J; Davison J; Lambert M; Carter R
    Aust N Z J Public Health; 2019 Oct; 43(5):484-495. PubMed ID: 31390112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.
    Paz-Zulueta M; Parás-Bravo P; Cantarero-Prieto D; Blázquez-Fernández C; Oterino-Durán A
    Mult Scler Relat Disord; 2020 Aug; 43():102162. PubMed ID: 32442885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The cost of schizophrenia: a literature review].
    Charrier N; Chevreul K; Durand-Zaleski I
    Encephale; 2013 May; 39 Suppl 1():S49-56. PubMed ID: 23351935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cost of mental disorders: a systematic review.
    Christensen MK; Lim CCW; Saha S; Plana-Ripoll O; Cannon D; Presley F; Weye N; Momen NC; Whiteford HA; Iburg KM; McGrath JJ
    Epidemiol Psychiatr Sci; 2020 Aug; 29():e161. PubMed ID: 32807256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CP-North: living life in the Nordic countries? A retrospective register research protocol on individuals with cerebral palsy and their parents living in Sweden, Norway, Denmark, Finland and Iceland.
    Alriksson-Schmidt AI; Ahonen M; Andersen GL; Eggertsdóttir G; Haula T; Jahnsen R; Jarl J; Jeglinsky-Kankainen I; Jonsdottir G; Seid AK; Ásgeirsdóttir TL; Møller-Madsen B; Nordbye-Nielsen K; Saha S; Steskal D; Sääksvuori L; Hägglund G
    BMJ Open; 2019 Oct; 9(10):e024438. PubMed ID: 31575533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small class sizes for improving student achievement in primary and secondary schools: a systematic review.
    Filges T; Sonne-Schmidt CS; Nielsen BCV
    Campbell Syst Rev; 2018; 14(1):1-107. PubMed ID: 37131395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
    Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
    Elife; 2023 Aug; 12():. PubMed ID: 37534878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Economic Impact of Adult Hearing Loss: A Systematic Review.
    Huddle MG; Goman AM; Kernizan FC; Foley DM; Price C; Frick KD; Lin FR
    JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1040-1048. PubMed ID: 28796850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic burden of multiple sclerosis: a systematic review of the literature.
    Naci H; Fleurence R; Birt J; Duhig A
    Pharmacoeconomics; 2010; 28(5):363-79. PubMed ID: 20402540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015.
    Kiadaliri AA; Kristensen LE; Englund M
    Scand J Rheumatol; 2018 Mar; 47(2):1-101. PubMed ID: 28766390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lung cancer registries in Denmark, Finland, Norway and Sweden: a comparison and proposal for harmonization.
    Gouliaev A; Rasmussen TR; Malila N; Fjellbirkeland L; Löfling L; Jakobsen E; Dalton SO; Christensen NL
    Acta Oncol; 2023 Jan; 62(1):1-7. PubMed ID: 36718556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimates of excess mortality for the five Nordic countries during the COVID-19 pandemic 2020-2021.
    Kepp KP; Björk J; Kontis V; Parks RM; Bæk KT; Emilsson L; Lallukka T
    Int J Epidemiol; 2022 Dec; 51(6):1722-1732. PubMed ID: 36331437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.
    Srivastava K; Thakur D; Sharma S; Punekar YS
    Pharmacoeconomics; 2015 May; 33(5):467-88. PubMed ID: 25663178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.